111 research outputs found

    Global variations in diabetes mellitus based on fasting glucose and haemogloblin A1c

    Get PDF
    Fasting plasma glucose (FPG) and haemoglobin A1c (HbA1c) are both used to diagnose diabetes, but may identify different people as having diabetes. We used data from 117 population-based studies and quantified, in different world regions, the prevalence of diagnosed diabetes, and whether those who were previously undiagnosed and detected as having diabetes in survey screening had elevated FPG, HbA1c, or both. We developed prediction equations for estimating the probability that a person without previously diagnosed diabetes, and at a specific level of FPG, had elevated HbA1c, and vice versa. The age-standardised proportion of diabetes that was previously undiagnosed, and detected in survey screening, ranged from 30% in the high-income western region to 66% in south Asia. Among those with screen-detected diabetes with either test, the agestandardised proportion who had elevated levels of both FPG and HbA1c was 29-39% across regions; the remainder had discordant elevation of FPG or HbA1c. In most low- and middle-income regions, isolated elevated HbA1c more common than isolated elevated FPG. In these regions, the use of FPG alone may delay diabetes diagnosis and underestimate diabetes prevalence. Our prediction equations help allocate finite resources for measuring HbA1c to reduce the global gap in diabetes diagnosis and surveillance.peer-reviewe

    Measurement of the charge asymmetry in top-quark pair production in the lepton-plus-jets final state in pp collision data at s=8TeV\sqrt{s}=8\,\mathrm TeV{} with the ATLAS detector

    Get PDF

    ATLAS Run 1 searches for direct pair production of third-generation squarks at the Large Hadron Collider

    Get PDF

    The association between blood glucose levels and matrix-metalloproteinase-9 in early severe sepsis and septic shock

    No full text
    BACKGROUND: Hyperglycemia is a frequent and important metabolic derangement that accompanies severe sepsis and septic shock. Matrix-Metalloproteinase 9 (MMP-9) has been shown to be elevated in acute stress hyperglycemia, chronic hyperglycemia, and in patient with sepsis. The objective of this study was to examine the clinical and pathogenic link between MMP-9 and blood glucose (BG) levels in patients with early severe sepsis and septic shock. METHODS: We prospectively examined 230 patients with severe sepsis and septic shock immediately upon hospital presentation and before any treatment including insulin administration. Clinical and laboratory data were obtained along with blood samples for the purpose of this study. Univariate tests for mean and median distribution using Spearman correlation and analysis of variance (ANOVA) were performed. A p value ≤ 0.05 was considered statistically significant. RESULTS: Patients were grouped based on their presenting BG level (mg/dL): BG(n = 32), 80-120 (n = 53), 121-150 (n = 38), 151-200 (n = 23), and \u3e 201 (n = 84). Rising MMP-9 levels were significantly associated with rising BG levels (p = 0.043). A corresponding increase in the prevalence of diabetes for each glucose grouping from 6.3 to 54.1 % (p = 0.0001) was also found. As MMP-9 levels increased a significantly (p \u3c 0.001) decreases in IL-8 (pg/mL) and ICAM-1 (ng/mL) were noted. CONCLUSION: This is the first study in humans demonstrating a significant and early association between MMP-9 and BG levels in in patients with severe sepsis and septic shock. Neutrophil affecting biomarkers such as IL-8 and ICAM-1 are noted to decrease as MMP-9 levels increase. Clinical risk stratification using MMP-9 levels could potentially help determine which patients would benefit from intensive versus conventional insulin therapy. In addition, antagonizing the up-regulation of MMP-9 could serve as a potential treatment option in severe sepsis or septic shock patients

    SHM of bridges: characterising thermal response and detecting anomaly events using a temperature-based measurement interpretation approach

    Get PDF
    A major bottleneck preventing widespread use of Structural Health Monitoring (SHM) systems for bridges is the difficulty in making sense of the collected data. Characterising environmental effects in measured bridge behaviour, and in particular the influence of temperature variations, remains a significant challenge. This paper proposes a novel data-driven approach referred to as Temperature-Based Measurement Interpretation (TB-MI) approach to solve this challenge. The approach is composed of two key steps - (i) characterisation of thermal effects in bridges using a methodology referred to as Regression-Based Thermal Response Prediction (RBTRP) methodology, and (ii) detection of anomaly events by analysing differences between measured and predicted structural behaviour. Measurements from a laboratory truss structure that is setup to simulate a range of structural scenarios are employed to evaluate the performance of the TB-MI approach. The study examines how the predictive capability of the RBTRP methodology is influenced by dimensionality reduction and measurement down-sampling, which are common pre-processing techniques used to deal with high spatial and temporal density in measurements. It also proposes a novel anomaly detection technique referred to as signal subtraction method that detects anomaly events from time-series of prediction errors, which are computed as the difference between in-situ measurements and predictions obtained using the RBTRP methodology. Results demonstrate that the TB-MI approach has potential for integration within data interpretation frameworks of SHM systems of full-scale bridges.The authors would like to express their gratitude to Bill Harvey Associates and Pembrokshire County Council for providing access to the measurements of the Cleddau Bridge, and to Elena Barton (National Physical Laboratory) for providing the data from the National Physical Laboratory Footbridge project
    corecore